Suchergebnisse
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $2.4 per share a year ago. These figures
DarioHealth Q2 Earnings Call Highlights
Key Points
- Interested in DarioHealth Corp.? Here are five stocks we like better.
- Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
DTS Corp.
WKN: 892495 / Name: DTS / Aktie / Software & Informationsdienstleistungen / Micro Cap /
Nobilis Health Corp.
WKN: A12GGN / Symbol: NRTSF / Name: Nobilis Health / Aktie / Anbieter & Dienstleistungen / Micro Cap /
Medx Health Corp.
WKN: A0YJHF / Name: Medx Health / Aktie / Ausrüstung & Versorgung / Micro Cap /
Daihen Corp
WKN: 859037 / Name: Daihen / Aktie / Maschinen, Ausrüstung & Teile / Micro Cap /


